Department of Palliative, Rehabilitation, and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Department of Hematology and Oncology, West Virginia University School of Medicine, Morgantown, West, Virginia, USA.
Cancer. 2022 Sep 1;128(17):3155-3157. doi: 10.1002/cncr.34373. Epub 2022 Jul 5.
The study by Smith et al. on the Patient-Reported Outcomes Measurement Information System (PROMIS) Cancer Function Brief 3D Profile shows that it can be used to measure how an individual functions and how his or her function changes during cancer treatments. This is important because most patients will experience a decline in function during cancer treatment and will struggle to fully participate in their life roles. Strong evidence demonstrates that rehabilitation improves function for individuals with cancer; rehabilitation is relatively underutilized. We suggest that using the PROMIS tool as a repeated measure throughout cancer treatment will help to identify those with functional decline who will benefit most from rehabilitation.
史密斯等人对患者报告结局测量信息系统(PROMIS)癌症功能简要 3D 简介的研究表明,它可用于测量个体的功能以及在癌症治疗过程中其功能的变化情况。这一点很重要,因为大多数患者在癌症治疗期间会经历功能下降,并且难以充分参与其生活角色。强有力的证据表明,康复可改善癌症患者的功能;但康复的应用相对不足。我们建议,在癌症治疗过程中,将 PROMIS 工具作为一项重复测量手段,这将有助于确定那些功能下降的患者,他们将从康复中获益最多。